Clinical Briefings™: Optimizing Cosmetic Outcomes – Advances in Neurotoxic Agents and Biostimulatory Soft Tissue Fillers

Release Date: March 3, 2020
Expiration Date: March 3, 2021
Media: Internet - based

Activity Overview

Facial aging is the result of a combination of changes that involve the skin and underlying tissues. Overall, the changes that result from underlying volume loss and wrinkling associated with age and photodamage can produce a subjectively older appearance. This CME-certified activity entitled, “Clinical Briefings™: Optimizing Cosmetic Outcomes – Advances in Neurotoxic Agents and Biostimulatory Soft Tissue Fillers,” will help physicians select the right tools to optimize outcomes and increase patient satisfaction using a patient-tailored approach.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Allergan.

Target Audience

This online educational activity is directed toward dermatologists, plastic surgeons, facial plastic surgeons, ocular plastic surgeons, ophthalmologists, and medical professionals from the following disciplines: dermatology, plastic surgery, otolaryngology, ophthalmology, dermatologic surgery, cosmetic surgery, facial plastic surgery, and ocular plastic surgery. It may also be of benefit to nurses in the field of aesthetic medicine and other healthcare providers who are involved in aesthetic medicine.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

• Explicate the various soft-tissue filler and neurotoxin agents available determined by product characteristics, sites of correction, and safety
• Discuss optimization of cosmetic results through combined approach of neurotoxin and soft-tissue filler therapy
• Discern the clinical impact of recent advances in neurotoxin and soft-tissue filer agents in cosmetic care of patients

Faculty, Staff, and Planners’ Disclosures

Faculty

Sabrina Guillen Fabi, MD, FAAD, FAACS
Goldman Butterwick Groff Fabi & Wu, Cosmetic Laser Dermatology
Voluntary Assistant Clinical Professor in Medicine/Dermatology
University of California
San Diego, CA

Disclosures: Consultant: Allergan, Merz, Galderma, Revance, Bausch Health Companies Inc, Endo; Speakers Bureau: Allergan, Merz, Galderma; Stock/Shareholder: Allergan, Revance.

The staff of Physicians' Education Resource^®, LLC (PER^®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER^® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER^® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER^® is required by ACCME to resolve all COI. PER^® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^®.